Singapore's S$118 million Bioeconomy Funding Initiative: an IP perspective

Singapore has launched a S$118 million Bioeconomy Funding Initiative under its Research, Innovation and Enterprise (RIE) 2030 Plan to support research into bio-based chemicals, ingredients and materials. A key feature of the initiative is its focus on increasing the potential for real-world impact from public-sector research by aligning research capabilities with the needs of industry.

TheA initiative aims to translate research into commercially relevant outcomes, while fostering local start-ups and strengthening Singapore's position as a bioeconomy innovation hub. Research areas include sustainable raw materials, engineering microbes and enzyme pathways, industrial-scale bioprocessing and the development of bio-based products for commercial application.

IP considerations for collaborative R&D

Collaboration between businesses, universities and public research institutions can accelerate innovation, but it also makes early consideration of IP particularly important.

When entering into or progressing a collaborative research project, parties should consider the following.

• Background and newly developed IP: identifying the IP and know-how each party brings to the project, and considering at an early stage how ownership of IP arising from the collaboration, and rights to use and commercialise that IP, will be addressed.
• Inventorship and entitlement: ensuring that contributions to inventions are properly identified and documented, particularly where researchers from different organisations work together, and identifying potential ownership or entitlement issues that may affect patent protection.
• Confidentiality and disclosure: having appropriate confidentiality and publication arrangements in place so that potentially patentable inventions can be identified and protected before public disclosure, which may otherwise prejudice the availability of patent protection.
• Patents and trade secrets: considering whether innovations should be patented or whether commercially valuable processes, production methods and know-how may be better protected as confidential information or trade secrets.
• Freedom to operate: assessing relevant third-party IP rights that could affect the ability to commercialise resulting technologies.
• Commercialisation: considering how the patent portfolio can support the intended route to commercialisation, including identifying IP protection that may be important for future licensing or other commercial activities.

How we can help

Singapore's increased investment in the bioeconomy creates significant opportunities for collaboration between public research institutions and industry. Considering IP issues at the outset can help collaborators protect their respective contributions, reduce the risk of later disputes and establish a clearer route to commercialisation.

Marks & Clerk Singapore advises on patent strategy, inventorship, patent ownership and entitlement issues, freedom to operate, and strategies for protecting and commercialising inventions arising from collaborative R&D.

If you would like to discuss the IP implications of a proposed bioeconomy collaboration, please contact our team at mail@marks-clerk.com.sg.

Subscribe to receive more articles like this here.

Singapore's increased investment in the bioeconomy creates significant opportunities for collaboration between public research institutions and industry. Considering IP issues at the outset can help collaborators protect their respective contributions, reduce the risk of later disputes and establish a clearer route to commercialisation.